Profile of alglucosidase alfa in the treatment of Pompe disease: safety, efficacy, and patient acceptability
Research and Reports in Endocrine Disorders · 2016
DOI: 10.2147/rred.s72834 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research and Reports in Endocrine Disorders, 2016. Verfasst von Ilka Schneider und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Schneider, I., & Zierz, S. (2016). Profile of alglucosidase alfa in the treatment of Pompe disease: safety, efficacy, and patient acceptability. Research and Reports in Endocrine Disorders. https://doi.org/10.2147/rred.s72834
Vancouver
Schneider I, Zierz S. Profile of alglucosidase alfa in the treatment of Pompe disease: safety, efficacy, and patient acceptability. Research and Reports in Endocrine Disorders. 2016. doi:10.2147/rred.s72834
BibTeX
@article{Schneider2016,
author = {Schneider, Ilka and Zierz, Stephan},
title = {Profile of alglucosidase alfa in the treatment of Pompe disease: safety, efficacy, and patient acceptability},
journal = {Research and Reports in Endocrine Disorders},
year = {2016},
doi = {10.2147/rred.s72834}
}
EUVIMED